Results 51 to 60 of about 4,827,573 (297)

Engineering the fitness of older patients for chemotherapy : an exploration of Comprehensive Geriatric Assessment in practice [PDF]

open access: yes, 2014
Clinicians often report that currently available methods to assess older patients, including standard clinical consultations, do not elicit the information necessary to make an appropriate cancer treatment recommendation for older cancer patients.
Yates, Patsy   +3 more
core   +3 more sources

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub   +24 more
wiley   +1 more source

Understanding Pathways into Care-homes using Data (UnPiCD study): a two-part model to estimate inpatient and care-home costs using national linked health and social care data

open access: yesBMC Health Services Research
Background Pathways into care-homes have been under-researched. Individuals who move-in to a care-home from hospital are clinically distinct from those moving-in from the community.
G. Ciminata   +3 more
doaj   +1 more source

Comprehensive geriatric assessment in cardiovascular disease

open access: yes, 2018
Comprehensive geriatric assessment (CGA) is an efficient and effective way for evaluating complex elderly patients and for planning improved care based on CGA findings.
Andreas W. Schoenenberger   +1 more
core   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Risk factors of linezolid-associated hyponatremia from a retrospective case–control study: decreased serum albumin as a selective predictor in elder patients

open access: yesAnnals of Medicine
Background The incidence of linezolid-associated hyponatremia is approximately 20% in real-world studies. However, there are limited case reports and rare research on linezolid-induced hyponatremia.
Liang Liang   +7 more
doaj   +1 more source

Impairment of various domains of comprehensive geriatric assessment (N = 178).

open access: yes, 2023
Impairment of various domains of comprehensive geriatric assessment (N = 178).
Li-Chueh Weng (4030628)   +6 more
core   +1 more source

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang   +23 more
wiley   +1 more source

Baseline characteristics including geriatric assessment (N = 1284).

open access: yes, 2015
Baseline characteristics including geriatric assessment (N = 1284).
Jin Won Kim (224828)   +7 more
core   +1 more source

Geriatric assessment: Domains, measures, and cut-off values for impairments.

open access: yes, 2023
Geriatric assessment: Domains, measures, and cut-off values for impairments.
Bjørn Henning Grønberg (4222687)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy